1. Home
  2. GHRS vs RWT Comparison

GHRS vs RWT Comparison

Compare GHRS & RWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHRS
  • RWT
  • Stock Information
  • Founded
  • GHRS 2018
  • RWT 1994
  • Country
  • GHRS Ireland
  • RWT United States
  • Employees
  • GHRS N/A
  • RWT N/A
  • Industry
  • GHRS Biotechnology: Pharmaceutical Preparations
  • RWT Real Estate Investment Trusts
  • Sector
  • GHRS Health Care
  • RWT Real Estate
  • Exchange
  • GHRS Nasdaq
  • RWT Nasdaq
  • Market Cap
  • GHRS 849.8M
  • RWT 756.1M
  • IPO Year
  • GHRS 2021
  • RWT 1995
  • Fundamental
  • Price
  • GHRS $12.31
  • RWT $5.63
  • Analyst Decision
  • GHRS Strong Buy
  • RWT Buy
  • Analyst Count
  • GHRS 8
  • RWT 11
  • Target Price
  • GHRS $30.63
  • RWT $7.59
  • AVG Volume (30 Days)
  • GHRS 187.6K
  • RWT 703.1K
  • Earning Date
  • GHRS 05-08-2025
  • RWT 07-31-2025
  • Dividend Yield
  • GHRS N/A
  • RWT 12.77%
  • EPS Growth
  • GHRS N/A
  • RWT 105.35
  • EPS
  • GHRS N/A
  • RWT 0.21
  • Revenue
  • GHRS N/A
  • RWT $241,796,000.00
  • Revenue This Year
  • GHRS N/A
  • RWT N/A
  • Revenue Next Year
  • GHRS N/A
  • RWT $3.43
  • P/E Ratio
  • GHRS N/A
  • RWT $26.74
  • Revenue Growth
  • GHRS N/A
  • RWT 29.65
  • 52 Week Low
  • GHRS $6.00
  • RWT $4.68
  • 52 Week High
  • GHRS $20.50
  • RWT $8.15
  • Technical
  • Relative Strength Index (RSI)
  • GHRS 52.37
  • RWT 47.62
  • Support Level
  • GHRS $12.43
  • RWT $5.67
  • Resistance Level
  • GHRS $13.15
  • RWT $5.91
  • Average True Range (ATR)
  • GHRS 0.99
  • RWT 0.12
  • MACD
  • GHRS -0.14
  • RWT 0.01
  • Stochastic Oscillator
  • GHRS 41.03
  • RWT 49.11

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

About RWT Redwood Trust Inc.

Redwood Trust Inc is a real estate investment trust focused on different areas of housing credit. The company operates in three segments: Sequoia Mortgage Banking includes mortgage loan conduit that acquires residential consumer loans from third-party originators for sale to whole loan buyers and securitization; CoreVest Mortgage Banking segment includes consists of a platform that originates residential investor loans for securitization, sale, or transfer into Redwood Investments portfolio; and Redwood Investments segment consists of organic investments sourced through mortgage banking operations, including securities retained from Sequoia and CoreVest securitization activities. It derives maximum revenue from Redwood Investments segment.

Share on Social Networks: